No black box warning on record for Zurzuvae

As of the latest FDA labeling reviewed, Zurzuvae (ZURANOLONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Zurzuvae medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS CNS Depressant Effects: ZURZUVAE can cause CNS depressant effects such as somnolence and confusion. If patients develop CNS depression, consider dosage reduction or discontinuation of ZURZUVAE. ( 5.2 ) Suicidal Thoughts and Behavior: Consider changing the therapeutic regimen, including discontinuing ZURZUVAE, in patients whose PPD worsens, or who experience emergent suic

No black box warning on record for Zurzuvae

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS CNS Depressant Effects: ZURZUVAE can cause CNS depressant effects such as somnolence and confusion. If patients develop CNS depression, consider dosage reduction or discontinuation of ZURZUVAE. ( 5.2 ) Suicidal Thoughts and Behavior: Consider changing the therapeutic regimen, including discontinuing ZURZUVAE, in patients whose PPD worsens, or who experience emergent suic

Zurzuvae Black Box Warning

No black box warning on record for Zurzuvae

Other warnings & precautions

Zurzuvae Black Box Warning

No black box warning on record for Zurzuvae

Other warnings & precautions